POST Facilitation for Post-Traumatic Stress Disorder
(POST-RCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how POST Facilitation—guidance on completing a medical treatment form—can assist older adults with normal cognition or Alzheimer's and similar disorders. The researchers aim to determine if this process helps patients and their families better understand and prepare for medical care decisions. Participants will receive either a home visit for POST education or a home safety evaluation. Individuals 65 and older who are not in hospice care and can make decisions or have a decision-maker qualify for participation. As an unphased trial, this study offers participants the chance to contribute to research that may enhance decision-making processes for future patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that POST Facilitation is safe for older adults?
Research shows that POST Facilitation, the treatment under study, is generally considered safe as it is a type of psychological therapy. Studies have found that psychological therapies for conditions like PTSD (post-traumatic stress disorder) are effective and usually well-tolerated by patients. Although specific safety data for POST Facilitation is not yet available, similar therapies have proven effective and beneficial, suggesting it is likely safe for participants. Since this trial is marked "Not Applicable" for traditional phases, it likely involves a non-drug treatment, which typically carries a lower risk of side effects.12345
Why are researchers excited about this trial?
Researchers are excited about POST Facilitation for PTSD because it focuses on patient education and family involvement, which is a unique approach compared to traditional therapies like cognitive behavioral therapy and medication. Unlike these standard treatments, POST Facilitation involves trained nurses conducting home visits to educate patients and their families about the Physician Orders for Scope of Treatment (POST) form, promoting proactive planning and decision-making. This method aims to empower patients and their families, enhancing their understanding and management of PTSD in a more personalized and supportive environment.
What evidence suggests that POST Facilitation is effective for Post-Traumatic Stress Disorder?
Research has shown that psychological treatments can be very effective for PTSD (Post-Traumatic Stress Disorder). A review of several studies found strong evidence supporting these treatments. One study reported that 91% of participants experienced a significant reduction in PTSD symptoms after treatment. Another study found that 63.53% of participants improved with trauma-focused treatment for PTSD. In this trial, participants will receive either POST Facilitation or a Home Safety Evaluation. These findings suggest that methods like POST Facilitation, which participants in this trial may receive, could help reduce PTSD symptoms.35678
Who Is on the Research Team?
Alexia M Torke, MD
Principal Investigator
Regenstrief Institute, Indiana University
Are You a Good Fit for This Trial?
This trial is for community-dwelling older adults aged 65 or above with certain serious health conditions like metastatic cancer, heart failure, kidney disease, COPD, or advanced Alzheimer's. They must have a high risk of mortality within a year and either be able to make decisions themselves or have a surrogate decision maker. Those already in hospice care or with an existing POST form are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive POST Facilitation or Home Safety Evaluation
Follow-up
Participants are monitored for outcomes such as decision conflict, psychological well-being, and POST form completion
Outcome Assessment
Assessment of primary and secondary outcomes including discordance between treatment preferences and treatment received
What Are the Treatments Tested in This Trial?
Interventions
- Home Safety Evaluation
- POST Facilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Aging (NIA)
Collaborator
Regenstrief Institute, Inc.
Collaborator
Indiana University Health
Collaborator
Eskenazi Health
Collaborator
Respecting Choices
Collaborator